Studies show that BDNF is reduced in people with dementia, mild cognitive impairment (MCI), and AD and that higher BDNF in the brain [25–30] and systemic circulation [31–38] is associated with a slower rate of cognitive decline in individuals diagnosed with MCI or AD. This evidence concerns the gene BDNF and Mental deterioration.